Newsroom

Newsroom

Gordon Smith

Press Release

October 4, 2022
Clayton, Dubilier & Rice announced Gordon Smith, former Co-President and Chief Operating Officer of JPMorgan Chase & Co., as an Operating Advisor to CD&R funds. Mr. Smith will work with CD&R's financial services team to help source...
Mike Lamach

Press Release

September 14, 2022
Clayton, Dubilier & Rice announced Michael Lamach, who previously served as Executive Chair and Chief Executive Officer of Trane Technologies (formerly Ingersoll-Rand), has been appointed as an Operating Advisor to CD&R funds.
David Winokur

Press Release

September 6, 2022
Clayton, Dubilier & Rice announced the appointment of David Winokur, an experienced financial services investor, as a Partner at the firm. In his new role, Mr. Winokur will build the newly created financial services vertical and be engaged in...
Caregiver with a patient.

Press Release

August 11, 2022
Humana Inc. (NYSE: HUM) today announced that it has successfully completed its previously-announced transaction with private investment firm Clayton, Dubilier & Rice (“CD&R”) to divest a majority interest in the Hospice and Personal Care...
CDR Foundation London Grantee Logos.

Press Release

August 2, 2022
Clayton Dubilier & Rice (“CD&R” or the “Firm”) today announced that the CD&R Foundation (the “Foundation”) has made grants totaling approximately £2.4 million to three non-profit organisations in the United Kingdom over the next three...
Dave Novak.

Perspectives

July 28, 2022
Dave Novak, Co-President of CD&R, recently appeared on the Money Maze Podcast to discuss the evolution of private equity over the past four decades, and how it can drive business efficiency and value creation. Speaking to Simon Brewer, Co-...
Cleaner.

Press Release

July 28, 2022
Clayton, Dubilier & Rice (“CD&R”) announced agreements under which CD&R Fund XI and affiliates will acquire the Facilities Services business of OCS Group (“OCS”) and have made a binding and irrevocable offer to acquire Atalian, approval...
Robert Quarta

Events

July 26, 2022
Leader Capital’s Private Markets 2022 Summit brought together more than 300 Israeli and global senior industry professionals, including leading Israeli limited partners, global fund managers and advisors to discuss a range of critical topics and...
Epicor Industry Insights Image.

Perspectives

July 26, 2022
According to a recent research study from Epicor, a global leader of industry-specific enterprise software designed to promote business growth, a resounding 96 percent of organizations surveyed worldwide have confidence in their ability to navigate...
Cornerstone.

Press Release

July 25, 2022
Cornerstone Building Brands, Inc. (“Cornerstone Building Brands” or the “Company”), the largest manufacturer of exterior building products in North America, today announced that Clayton, Dubilier & Rice (“CD&R”) has successfully completed...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...

Events

December 7, 2021
CD&R Chairman Don Gogel joined Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC), in a London Business School fireside chat titled, “In conversation with Don Gogel: private capital in...
Screen shot from video
Play Video

Events

December 7, 2021
CD&R Chairman Don Gogel discusses trends and opportunities in private capital with Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC) at London Business School. The video below...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.